An Effectiveness Evaluation of a Primary Care-Embedded Clinical Pharmacist-Led Intervention Among Blacks with Diabetes.

Journal of General Internal Medicine
Kimberly Danae Cauley NarainCarol M Mangione

Abstract

Black individuals with type 2 diabetes suffer disproportionate morbidity and mortality relative to whites with type 2 diabetes, irrespective of health insurance coverage. Examine the impact of a primary care-embedded clinical pharmacist-led intervention (UCMyRx) on cardiovascular risk factor control among blacks with type 2 diabetes in a large healthcare system. We used data extracted from the electronic health records (EHR) system and a difference-in-differences study design with a propensity-matched comparison group to evaluate the impact of UCMyRx on HbA1c and systolic blood pressure (SBP) among black patients with type 2 diabetes, relative to usual care. Individuals with type 2 diabetes identified as either black or African American in the EHR that were ≥ 18 years of age that had the following observations during the study window (03/02/2013-12/31/18: (1) HbA1C ≥ 8%, at least once, anywhere between 365 days before and 14 days after the UCMyRx visit and a follow-up HbA1c measure within 120 to 365 days after the visit and/or (2) SBP ≥ 140 mmHg at least once between 365 days before and 14 days after the UCMyRx visit that had a follow-up SBP measure within 120 to 450 days after the visit. UCMyRx pharmacists review labs and vita...Continue Reading

References

Mar 1, 1996·The Annals of Pharmacotherapy·L A JaberH Diwakaran
Jun 15, 2007·Diabetes Technology & Therapeutics·Timothy S BaileySatish K Garg
Oct 19, 2007·Medical Care Research and Review : MCRR·Monica E PeekElbert S Huang
Feb 10, 2009·BMC Health Services Research·Connie M TrinactyDennis Ross-Degnan
May 5, 2010·The American Journal of Geriatric Pharmacotherapy·Ben S GerberShoou-Yih D Lee
Sep 29, 2011·Journal of Health Communication·Chandra Y OsbornRichard O White
Jan 5, 2014·Clinical and Translational Gastroenterology·Amit G SingalAkbar K Waljee
Dec 17, 2014·World Journal of Diabetes·James X ZhangDavid O Meltzer
Dec 23, 2014·Health Services & Outcomes Research Methodology·Elizabeth A StuartColleen L Barry
May 9, 2015·Journal of the American Geriatrics Society·Rituparna BhattacharyaUsha Sambamoorthi
May 23, 2015·American Journal of Preventive Medicine·Ronald T AckermannUNKNOWN NEXT-D Study Group
Jul 3, 2016·Applied Health Economics and Health Policy·Huanxue ZhouYunfeng Li
Jan 13, 2017·Journal of Racial and Ethnic Health Disparities·Juan R CanedoMaureen Sanderson
Mar 23, 2017·Diabetes Care·Rita R KalyaniWilliam T Cefalu
Mar 24, 2018·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Jul 15, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Jarred Prudencio, Michelle Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
Russell RothmanMichael Pignone
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
April HindsVictoria Seaton
© 2021 Meta ULC. All rights reserved